The E-64 Shop Dash Board Widget

It was important for pharmacists to have the opportunity to perform and document clinical pharmacy interventions that they felt patients needed but may not exist in www.selleckchem.com/products/r428.html the checklist. These ��other�� clinical pharmacy interventions were documented as free text. Data analysis Quantitative data were analysed using SPSS? version 19. Descriptive statistics were used for the number, type and frequency of clinical pharmacy interventions delivered. The original clinical pharmacy interventions from the checklist were analysed thematically. Five researchers analysed the data after the service was delivered and met to reach consensus on the themes. Nine themes were identified; all of the clinical pharmacy interventions were able to be included under one of these themes. The free text ��other�� clinical pharmacy interventions were independently analysed by 2 experienced pharmacist researchers who subsequently discussed their analysis and reached http://www.selleckchem.com/products/jq1.html consensus on a coding frame. These ��other�� clinical pharmacy interventions were reclassified as one of the original clinical pharmacy interventions in the checklist (and included in the descriptive analysis) or new interventions. The new clinical pharmacy interventions derived from the free text ��other�� interventions data were not included in the thematic analysis, as they were not provided to pharmacists in the checklist. RESULTS There were 570 patients recruited into PAMS at baseline, of whom, 475 attended Visit 2, 200 attended Visit 3 (this visit was only applicable to the patients in the 4-visit service) and 398 attended the Final Visit. The E-64 clinical outcomes of the service have been reported elsewhere.13 Since there was no significant difference in the outcomes between the 3-visit service and the 4-visit service13, the clinical pharmacy interventions have been pooled for all patients for this analysis. The pharmacists performed a total of 22,909 clinical pharmacy interventions over the 6-month service, 41% of which were performed at the first visit. While, on average, patients received a higher number of clinical pharmacy interventions at Visit 1 (16.4 per patient), there were still a substantial number of clinical pharmacy interventions being delivered to each patient at the end of the service (12.3 per patient) (Figure 1). Figure 1 Mean number of interventions provided to each patient by the pharmacists per visit. The 6 most commonly delivered clinical pharmacy interventions at Visit 1 were ��counsel patient on trigger factors�� (92%), ��counsel patients on benefits of taking preventer medication�� (85%), ��demonstrate the best way to use the device�� (84%), ��misunderstanding of disease process �C counsel on the episodic nature of asthma and appropriate management�� (82%), ��counsel on safe use of reliever�� (81%), and ��clarify inaccurate perceptions about asthma and treatment (80%).